231231
2-Methoxybenzonitrile
99%
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
CH3OC6H4CN
CAS Number:
Molecular Weight:
133.15
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
229-559-0
MDL number:
Assay:
99%
Form:
liquid
InChI key
FSTPMFASNVISBU-UHFFFAOYSA-N
InChI
1S/C8H7NO/c1-10-8-5-3-2-4-7(8)6-9/h2-5H,1H3
SMILES string
COc1ccccc1C#N
assay
99%
form
liquid
refractive index
n20/D 1.5465 (lit.)
bp
135 °C/12 mmHg (lit.)
density
1.093 g/mL at 25 °C (lit.)
functional group
nitrile
General description
Surface-enhanced Raman spectra study of 2-methoxybenzonitrile has been reported.
Application
2-Methoxybenzonitrile was used in the synthesis of 5-(4′-methyl [1,1′-biphenyl]-2-yl)-1H-tetrazole.
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
235.4 °F - closed cup
flash_point_c
113 °C - closed cup
ppe
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Efficient synthesis of 5-(4'-methyl [1, 1'-biphenyl]-2-yl)-1H-tetrazole.
Russell RK and Murray WV.
The Journal of Organic Chemistry, 58(18), 5023-5024 (1993)
[Catalysts for demethylation of methoxybenzonitrile in liquid-phase (author's transl)].
H Kashiwagi et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 100(6), 668-671 (1980-06-01)
Guillermo Diaz Fleming et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 71(3), 1074-1079 (2008-04-29)
The SERS modelling of o-, m-, and p-methoxybenzonitrile has been performed following the same methodology that in Part I. Optimized structure obtained from DFT calculations in a B3LYP-LANL2DZ level of calculation shows different tilted positions for the isomers under study.
Leandro Val Sayson et al.
Psychopharmacology, 236(7), 2201-2210 (2019-03-21)
Depressive syndrome or depression is a debilitating brain disorder affecting numerous people worldwide. Although readily available, current antidepressants have low remission rates and late onset times. Recently, N-methyl-D-aspartate (NMDA) receptor antagonists, like ketamine and methoxetamine (MXE), were found to elicit
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service